Cargando…

Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy

BACKGROUND. In the U.S., neoadjuvant chemotherapy (NAC) for nonmetastatic breast cancer (BC) is used with extensive disease and aggressive molecular subtypes. Little is known about the influence of demographic characteristics, clinical factors, and resource constraints on NAC use in Africa. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Neil, Daniel S., Nietz, Sarah, Buccimazza, Ines, Singh, Urishka, Čačala, Sharon, Stopforth, Laura W., Joffe, Maureen, Jacobson, Judith S., Neugut, Alfred I., Crew, Katherine D., Ruff, Paul, Cubasch, Herbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2018
Materias:	Global Health and Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656461/ https://www.ncbi.nlm.nih.gov/pubmed/30518615 http://dx.doi.org/10.1634/theoncologist.2018-0535

Ejemplares similares

The Impact of HIV Infection on Neoadjuvant and Adjuvant Chemotherapy Relative Dose Intensity in South African Patients with Breast Cancer
por: O’Neil, Daniel S, et al.
Publicado: (2023)

The Impact of Breast Cancer Treatment Delays on Survival Among South African Women
por: Pumpalova, Yoanna S, et al.
Publicado: (2022)

Breast Cancer Care Quality in South Africa’s Public Health System: An Evaluation Using American Society of Clinical Oncology/National Quality Forum Measures
por: O’Neil, Daniel S., et al.
Publicado: (2019)

South African Breast Cancer and HIV Outcomes Study: Methods and Baseline Assessment
por: Cubasch, Herbert, et al.
Publicado: (2016)

Neoadjuvant chemotherapy among patients treated for nonmetastatic breast cancer in a population with a high HIV prevalence in Johannesburg, South Africa
por: Ruff, Paul, et al.
Publicado: (2018)

The South African breast cancer and HIV outcomes study: Profiling the cancer centres and cohort characteristics, diagnostic pathways, and treatment approaches
por: Mapanga, Witness, et al.
Publicado: (2023)

Multimorbidity and overall survival among women with breast cancer: results from the South African Breast Cancer and HIV Outcomes Study
por: Ayeni, Oluwatosin A., et al.
Publicado: (2023)

Drivers of disparities in stage at diagnosis among women with breast cancer: South African breast cancers and HIV outcomes cohort
por: Mapanga, Witness, et al.
Publicado: (2023)

Correction: Multimorbidity and overall survival among women with breast cancer: results from the South African Breast Cancer and HIV Outcomes Study
por: Ayeni, Oluwatosin A., et al.
Publicado: (2023)

Quality of Histopathological Reporting in Breast Cancer: Results From Four South African Breast Units
por: Toma, Armand, et al.
Publicado: (2021)

Survival of south african women with breast cancer receiving anti-retroviral therapy for HIV
por: Phakathi, Boitumelo, et al.
Publicado: (2021)

PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients—a South African cohort study
por: Phakathi, Boitumelo, et al.
Publicado: (2023)

Breast conservation surgery versus total mastectomy among women with localized breast cancer in Soweto, South Africa
por: Cubasch, Herbert, et al.
Publicado: (2017)

Barriers to early presentation of breast cancer among women in Soweto, South Africa
por: Joffe, Maureen, et al.
Publicado: (2018)

Patient Characteristics and Outcomes of Nonmetastatic Breast Cancer in Haiti: Results from a Retrospective Cohort
por: Fadelu, Temidayo, et al.
Publicado: (2020)

FGFR2 genetic variants in women with breast cancer
por: Dix-Peek, Thérèse, et al.
Publicado: (2023)

Illness Understanding and End-of-Life Care Communication and Preferences for Patients With Advanced Cancer in South Africa
por: Shen, Megan Johnson, et al.
Publicado: (2018)

Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer
por: Dix-Peek, Thérèse, et al.
Publicado: (2023)

Breast cancer characteristics and HIV among 1,092 women in Soweto, South Africa
por: Cubasch, Herbert, et al.
Publicado: (2013)

Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series
por: McCormack, Valerie A, et al.
Publicado: (2013)

National Cancer Database report of nonmetastatic esophageal small cell carcinoma
por: Verma, Vivek, et al.
Publicado: (2018)

Pathological Response to Neoadjuvant Chemotherapy and the Molecular Classification of Locally Advanced Breast Cancer in a Latin American Cohort
por: Díaz‐Casas, Sandra Esperanza, et al.
Publicado: (2019)

Neoadjuvant Therapy in Nonmetastatic Breast Cancer in Kurdistan, Iraq
por: Namiq, Karez Sarbast, et al.
Publicado: (2023)

Perspectives on common chronic diseases in adult cancer patients in South Africa
por: Joffe, Maureen, et al.
Publicado: (2023)

Preexisting morbidity profile of women newly diagnosed with breast cancer in sub‐Saharan Africa: African Breast Cancer—Disparities in Outcomes study
por: Ayeni, Oluwatosin A., et al.
Publicado: (2020)

Time‐dependent and nonlinear effects of prognostic factors in nonmetastatic colorectal cancer
por: Chi, Sheng‐Qiang, et al.
Publicado: (2017)

The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer
por: Gruhl, Joshua D., et al.
Publicado: (2020)

Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population‐based study
por: Bao, Shengnan, et al.
Publicado: (2021)

Drivers of advanced stage at breast cancer diagnosis in the multicountry African breast cancer – disparities in outcomes (ABC‐DO) study
por: McKenzie, Fiona, et al.
Publicado: (2017)

Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy
por: Kool, Ronald, et al.
Publicado: (2021)

Clinical significance of glycoprotein nonmetastatic B and its association with HER2 in breast cancer
por: Kanematsu, Masako, et al.
Publicado: (2015)

Patient and caregiver benefit‐risk preferences for nonmetastatic castration‐resistant prostate cancer treatment
por: Srinivas, Sandy, et al.
Publicado: (2020)

Factors associated with cognitive impairment during the first year of treatment for nonmetastatic breast cancer
por: Rodriguez, Nicole, et al.
Publicado: (2021)

Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives
por: Cassese, Gianluca, et al.
Publicado: (2023)

Trends in treatment and survival of patients with nonresected, nonmetastatic pancreatic cancer: A population‐based study
por: van der Geest, Lydia G. M., et al.
Publicado: (2018)

Development and validation of a nomogram to predict survival after curative resection of nonmetastatic colorectal cancer
por: Hong, Tingting, et al.
Publicado: (2020)

Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma
por: Piccinelli, Mattia L., et al.
Publicado: (2023)

Phase I trial of TAK‐385 in hormone treatment‐naïve Japanese patients with nonmetastatic prostate cancer
por: Suzuki, Hiroyoshi, et al.
Publicado: (2019)

Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma
por: Shao, Yanxiang, et al.
Publicado: (2019)

Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States
por: Abdel-Rahman, Omar, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f4s0b8dufp3i03tno2ng8bdfmf